BRIUMVI
TG Therapeutics, Inc.
Mark For: BRIUMVI™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90760688 |
| Mark Literal Elements | BRIUMVI |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2022-05-31 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Maury M. Tepper, III |
Timeline
| 2021-06-08 | Application Filed |
| 2021-06-11 | Location: NEW APPLICATION PROCESSING |
| 2021-06-11 | Status: Live/Pending |
| 2021-06-11 | Transaction Date |
| 2022-04-05 | Published |
| 2022-05-31 | Location: INTENT TO USE SECTION |
| 2022-11-27 | Status: A first request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  TG Therapeutics, Inc. |
| Address | 2 Gansevoort Street, 9th Floor New York, NEW YORK UNITED STATES 10014 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Application | 2021-06-08 | |
| Drawing | 2021-06-08 | |
| Preliminary Amendment | 2021-10-18 | |
| Amendment and Mail Process Complete | 2021-10-19 | |
| XSearch Search Summary | 2022-02-25 | |
| TRAM Snapshot of App at Pub for Oppostn | 2022-03-01 | |
| Notice of Publication | 2022-03-16 | |
| Notification Of Notice of Publication | 2022-03-16 | |
| OG Publication Confirmation | 2022-04-05 | |
| Notice of Allowance | 2022-05-31 | |
| Extension of Time to File SOU | 2022-11-27 | |
| ITU Extension Approval | 2022-11-29 | |
| ITU Unit Action | 2022-11-29 |
Attorney of Record
Good, Services, and Codes
IC 005. US 005 006 018 044 046 051 052. G & S: pharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of central nervous system disorders, multiple sclerosis, autoimmune diseases and B-cell mediated non-oncological diseases
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical preparations for human use |
| GS0051 | Pharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of multiple sclerosis |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-11-29 | |
| TEAS EXTENSION RECEIVED | 2022-11-27 | |
| SOU EXTENSION 1 GRANTED | 2022-11-27 | 98765 |
| SOU EXTENSION 1 FILED | 2022-11-27 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-05-31 | |
| PUBLISHED FOR OPPOSITION | 2022-04-05 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-04-05 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-03-16 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-02-28 | |
| ASSIGNED TO EXAMINER | 2022-02-25 | 96117 |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2021-10-18 | |
| TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | 2021-10-18 | 88889 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-08-28 | |
| NEW APPLICATION ENTERED IN TRAM | 2021-06-11 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BRIUMVI 90760688 not registered Live/Pending |
TG Therapeutics, Inc. 2021-06-08 |
 BRIUMVI 88711952 not registered Live/Pending |
TG Therapeutics 2019-12-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 